Semaglutide side effects: what to expect and when to act

The side effects most people actually experience

The gut bears the brunt. Nausea, loose stools, constipation, vomiting, indigestion and burping are the effects you will see most often in the data, and they track closely with what patients report in practice. They typically peak in the first one to two weeks after a new dose and then ease as your body adjusts. Fatigue and headaches are also common, particularly early on, and injection-site reactions (redness or mild soreness where you inject) are straightforward and usually brief.

The slow-emptying effect that semaglutide has on the stomach is part of why it reduces appetite, but it is also the root cause of much of the GI discomfort. Eating smaller portions, staying well hydrated, and avoiding very fatty or spicy food during the early weeks all help. None of that is a substitute for what's in your Wegovy patient information leaflet, which covers practical management in full.

A question our prescribers hear most weeks is whether the nausea ever fully goes away. For most people it does settle; some carry a low-level awareness of it throughout treatment, particularly around eating. If you want a closer look at what side effects from Wegovy tend to involve in practice, that page walks through the experience in detail. Dose titration (moving up gradually rather than jumping to the highest dose quickly) is the main tool your prescriber has to keep this manageable. That is precisely why the schedule exists and why it is set by a clinician rather than left to you to decide.

The side effects that are less common but more serious

Acute pancreatitis is the most significant safety signal. In January 2026 the MHRA published a Drug Safety Update confirming it as an infrequent but potentially serious risk with GLP-1 medicines including semaglutide. The symptom to know is severe, persistent abdominal pain that radiates to the back, with or without vomiting. That combination warrants urgent medical assessment, not a wait-and-see approach.

Gallbladder problems (including gallstones and inflammation) appear at higher rates in people using GLP-1 medicines than in the general population, likely linked in part to rapid weight loss itself. If you develop sudden pain in your upper-right abdomen, especially after eating, tell a doctor the same day.

People with a history of medullary thyroid carcinoma or a condition called MEN2 should not use semaglutide; this is a contraindication checked during clinical assessment. For anyone with a personal or family history of thyroid tumours, a full conversation with a prescriber before starting is essential. More on the longer-term side-effect picture is worth reading if you are weighing up treatment over months or years.

When to get medical help

Some symptoms should not wait. Call 999 or go to A&E if you develop signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, difficulty breathing, or a sudden widespread rash alongside dizziness. These are rare but need immediate attention.

Contact a doctor or 111 the same day for: severe stomach pain that spreads to your back (possible pancreatitis); sudden changes in vision, particularly if you have diabetes; symptoms of dehydration from prolonged vomiting or diarrhoea — a dry mouth, dark urine, and feeling faint; or persistent low mood or thoughts of self-harm, which should always be taken seriously regardless of cause.

If you are unsure whether something you are experiencing is drug-related, reporting it via the MHRA Yellow Card scheme is open to patients as well as clinicians, and it actively improves the safety database for everyone using these medicines. You can also reach our aftercare team seven days a week if a question arises between doses.

How the decision to continue is made

The side-effect profile is real, but it does not affect everyone equally. Your prescriber looks at your starting dose, your medical history, any other medicines you take, and how your body responds at each step. Understanding what the side effects of taking semaglutide can include is a useful starting point before that conversation. If you transfer from another provider or move up a dose, the evidence on who is most likely to experience side effects is also worth reviewing.

NICE's appraisal of semaglutide notes that if less than five percent of body weight is lost after six months at the maintenance dose, continuing treatment should be reconsidered, which is itself a built-in checkpoint, not just a commercial one. That kind of structured review is part of what our clinical team builds into every repeat assessment, rather than simply issuing the next pen on request.

Semaglutide is a prescription-only medicine. If you are weighing up whether the likely benefits outweigh your personal risk profile, our full guide to what the side effects of Wegovy are covers the complete picture before you decide. Our prescribers discuss suitability and side effects as part of every assessment; start your free consultation to have that conversation with a GPhC-registered Independent Prescriber who will review your answers the same day.